LEUKOCERT
DEAD

Serial Number

98759613

Owner

Sanguine Biosciences, Inc.

Attorney

Elizabeth Oliner

Filing Date

Sep 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LEUKOCERT Trademark

Serial Number: 98759613

LEUKOCERT is a trademark filed by Sanguine Biosciences, Inc. on September 19, 2024. The trademark is classified under Class 1 (Chemicals), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Sanguine Biosciences, Inc. (8 trademarks)

400 W Cummings Park, Suite 3050
Woburn, MA 01801

Entity Type: 03

Trademark Details

Filing Date

September 19, 2024

Registration Date

Not Registered

Published for Opposition

April 29, 2025

Goods & Services

Distribution services, namely, delivery of cells, sub-cellular fractions, antibodies, reagents, culture media, and biological tissue, namely, immune cells, bone marrow, and pooled serum from either plasma or whole blood

Manufacturing and processing of cells in the field of cell therapies for medical and scientific research; Bone marrow aspiration for medical and scientific research; Research and development services in the field of cell therapies; Custom production and manufacture of advanced therapeutics such as cell and gene therapies for others for medical and scientific research; Leukapheresis collections from normal, healthy human donors for use as a source material for manufacturing and processing of cells for laboratory, medical and scientific research; Cell therapy services, namely, manufacturing and processing of Human AB serum and leukapheresis material for human biotherapies and in vivo therapies for laboratory, medical and scientific research; Medical services for cell sampling and isolation, namely, leukapheresis medical treatment services for laboratory, medical and scientific research

Cells, sub-cellular fractions, antibodies, reagents and culture media for scientific, laboratory, and research use; Immune cells isolated from leukapheresis collections by immunomagnetic or density gradient separation from normal, healthy human donors for scientific, laboratory, and research use; Human AB serum derived from either plasma or whole blood from normal, healthy male human donors with AB blood type for scientific, laboratory, research, and further manufacturing use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 26, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 26, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 24, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2025 CNSA
ASSIGNED TO EXAMINER
Mar 27, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2025 NWOS
NEW APPLICATION ENTERED
Sep 19, 2024 NWAP